Fortress Biotech, Inc.

NASDAQ:FBIO

Biotechnology

Healthcare
$1.77 -1.79%

-$0.06 today

Market cap
$59.03M
Beta
1.23
P/E (TTM)
0.7
EPS (TTM)
$4.05
52W Low $1.70High $4.53

Volume 0.19M

Average 0.43M

Income Statement

Follow revenue through to earnings.

Revenue

$63.26M

FY 2025 · Annual

+9.7% YoY

Operating Income

-$70.22M

FY 2025 · Annual

Net Income

$6.82M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue68.79M75.74M84.51M57.68M63.26M
Cost of Revenue32.08M30.78M22.89M20.88M20.92M
Gross Profit36.71M44.97M61.62M36.8M42.34M
Gross Margin53.4%59.4%72.9%63.8%66.9%
Research & Development128.87M134.88M106.07M56.88M11.9M
Selling, General & Admin86.84M113.66M90.98M87.73M96.4M
Operating Expenses225.25M248.53M203.96M147.18M112.56M
Depreciation & Amortization6.79M9.35M6M4.46M4.66M
EBITDA(146.17M)(193.69M)(135.72M)(104.49M)(20.17M)
EBITDA Margin-212.5%-255.7%-160.6%-181.2%-31.9%
Operating Income(188.54M)(203.56M)(142.34M)(110.38M)(70.22M)
Operating Margin-274.1%-268.8%-168.4%-191.4%-111.0%
Interest Income649K1.4M3M2.68M2.49M
Interest Expense15.31M13.64M12.52M9.93M8.71M
Other Income / Expenses24.19M(9.9M)(11.29M)(10.16M)36.69M
Income Before Tax(164.35M)(213.46M)(153.63M)(120.54M)(33.54M)
Pre-Tax Margin-238.9%-281.8%-181.8%-209.0%-53.0%
Income Tax Expense473K449K521K312K(620K)
Net Income(64.7M)(86.58M)(60.64M)(46M)6.82M
Net Margin-94.1%-114.3%-71.7%-79.8%10.8%
EPS (Basic)(11.85)(14.55)(8.47)(2.69)(0.07)
EPS (Diluted)(11.85)(14.55)(8.47)(2.69)(0.07)
Weighted Avg Shares5.45M5.93M8.11M20.78M27.9M
Weighted Avg Shares (Diluted)5.45M5.93M8.11M20.78M279.02M

FBIO Earnings Waterfall · TTM

NASDAQ:FBIO · Revenue to Net Income

Key Ratios

EPS$3.18
Gross Margin64.4%
Net Margin197.8%
P/E Ratio-0.3
P/S Ratio5.2

Analysis

$66.2M of revenue converted into $127.8M of net income for the selected period. Gross margin is 64.4% and net margin is 197.8%, showing how much revenue survives after costs and taxes. EPS is $3.18, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 13, 2026
10-QQuarterly reportNov 13, 2026
SC 13G/ASC 13G/A filingOct 29, 2026
8-KCurrent reportOct 1, 2026
4Statement of changes in beneficial ownershipOct 1, 2026

How much revenue does FBIO generate?

Fortress Biotech, Inc. (FBIO) reported $63.26M of revenue in fiscal 2025.

Is FBIO profitable?

Fortress Biotech, Inc. (FBIO) reported $6.82M of net income, with a net margin of 10.8%.